Nigeria is the first country in the world to roll out the new Men5CV vaccine. Men5CV protects recipients against five strains of the Neisseria meningitidis bacteria (A, C, W, Y and X).  

Nigeria is one of the 26 meningitis-endemic countries of Africa, in the area known as the Meningitis Belt. Between 1 October 2023 and 11 March 2024, Nigeria reported 1,742 suspected meningococcal C cases, including 101 confirmed cases and 153 deaths. 

The vaccination campaign aims to reach more than one million people aged 1 to 29 years. 

WHO: In world first, Nigeria introduces new 5-in-1 vaccine against meningitis

MVEC acknowledges the traditional owners of the lands on which we live, work and educate. We pay our respects to their Elders, past, present and emerging.
We are committed to honouring Australian Aboriginal and Torres Strait Islander peoples’ unique cultural and spiritual relationships to the land, waters and seas.

About MVEC

The Melbourne Vaccine Education Centre (MVEC) is an educational website, developed with the aim of providing up-to-date immunisation information for both healthcare professionals and members of the public. We are based at Murdoch Children’s Research Institute (MCRI), a research organisation, and are affiliated with SAEFVIC (Surveillance of Adverse Events Following Vaccination in the Community), the Victorian Vaccine Safety Service.

Share This